Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma

Histopathology

Volumn 59, Issue 4, 2011, Pages 643-649

  Kauppila, Joonas H ^a   Takala, Heikki ^a   Selander, Katri S ^a,b   Lehenkari, Petri P ^a   Saarnio, Juha ^a   Karttunen, Tuomo J ^a  

^a UNIVERSITY OF OULU   (Finland)

^b University of Alabama at Birmingham   (United States)

Author keywords

Oesophageal adenocarcinoma; Toll like receptor 9

Indexed keywords

TOLL LIKE RECEPTOR 9;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TOLL-LIKE RECEPTOR 9; TUMOR MARKERS, BIOLOGICAL;

EID: 80054906954     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03991.x     Document Type: Article

References (22)

1. Fukata M, Abreu MT. Pathogen recognition receptors, cancer and inflammation in the gut. Curr. Opin. Pharmacol. 2009; 9; 680-687.
2. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003; 21; 335-376.
3. Kaisho T, Akira S. Toll-like receptor function and signaling. J. Allergy Clin. Immunol. 2006; 117; 979-987; quiz 988.
4. Means TK, Luster AD. Toll-like receptor activation in the pathogenesis of systemic lupus erythematosus. Ann. NY Acad. Sci. 2005; 1062; 242-251.
5. Droemann D, Albrecht D, Gerdes J et al. Human lung cancer cells express functionally active Toll-like receptor 9. Respir. Res. 2005; 6; 1.
6. Schmausser B, Andrulis M, Endrich S, Muller-Hermelink HK, Eck M. Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. Int. J. Med. Microbiol. 2005; 295; 179-185.
7. Ilvesaro JM, Merrell MA, Swain TM et al. Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. Prostate 2007; 67; 774-781.
8. Chang YJ, Wu MS, Lin JT, Chen CC. Helicobacter pylori-induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation. J. Immunol. 2005; 175; 8242-8252.
9. Merrell MA, Ilvesaro JM, Lehtonen N et al. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol. Cancer Res. 2006; 4; 437-447.
10. Ren T, Wen ZK, Liu ZM, Liang YJ, Guo ZL, Xu L. Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis. Cancer Biol. Ther. 2007; 6; 1704-1709.
11. Holscher AH, Vallbohmer D, Bollschweiler E. Early Barrett's carcinoma of the esophagus. Ann. Thorac. Cardiovasc. Surg. 2008; 14; 347-354.
12. Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 2009; 137; 588-597.
13. Jukkola-Vuorinen A, Rahko E, Vuopala KS et al. Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer. J. Innate Immun. 2008; 1; 59-68.
14. Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408; 740-745.
15. Meng Y, Kujas M, Marie Y et al. Expression of TLR9 within human glioblastoma. J. Neurooncol. 2008; 88; 19-25.
16. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100; 57-70.
17. Xu L, Wang C, Wen Z et al. Selective up-regulation of CDK2 is critical for TLR9 signaling stimulated proliferation of human lung cancer cell. Immunol. Lett. 2010; 127; 93-99.
18. Rayburn ER, Wang W, Zhang Z, Li M, Zhang R, Wang H. Experimental therapy of prostate cancer with an immunomodulatory oligonucleotide: effects on tumor growth, apoptosis, proliferation, and potentiation of chemotherapy. Prostate 2006; 66; 1653-1663.
19. Qiu J, Wang X, Guo X, Zhao C, Wu X, Zhang Y. Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines. Oncol. Rep. 2009; 22; 935-941.
20. Akira S, Takeda K. Functions of toll-like receptors: lessons from KO mice. C. R. Biol. 2004; 327; 581-589.
21. Lande R, Gregorio J, Facchinetti V et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007; 449; 564-569.
22. Sachs G, Wen Y, Scott DR. Gastric infection by Helicobacter pylori. Curr. Gastroenterol. Rep. 2009; 11; 455-461.